drugset / Trial / NCT00621244
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study evaluated safety, tolerability, pharmacokinetics and preliminary anti-leukemic or anti-tumor activity of LBH589B in adult patients with advanced hematological malignancies
Timeline
- Start
- 2003-03-01
- Primary completion
- 2009-12-03
- Completion
- 2009-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panobinostat | Small molecule | — | Oral |